著書論文等- 髙木 清司 -
表示方法: 表示形式: 表示順:
[]:著書 []:論文 []:総説・解説記事
件数:103件
[2019]
1.[] Co-expression of carcinoembryonic antigen-related cell adhesion molecule 6 and 8 inhibits proliferation and invasiveness of breast carcinoma cells..[Clinical & experimental metastasis,36(5),(2019),423-432]Iwabuchi E, Miki Y, Onodera Y, Shibahara Y, Takagi K, Suzuki T, Ishida T, Sasano H
10.1007/s10585-019-09981-2
http://www.ncbi.nlm.nih.gov/pubmed/31222613
2.[] <i>ESR1</i>-stabilizing lncRNA <i>TMPO-AS1</i> promotes hormone-refractory breast cancer progression..[Molecular and cellular biology,(2019)]Mitobe Y, Ikeda K, Suzuki T, Takagi K, Kawabata H, Horie-Inoue K, Inoue S
10.1128/MCB.00261-19
http://www.ncbi.nlm.nih.gov/pubmed/31501276
3.[] ステロイドホルモン:量と作用を可視化する.[組織細胞化学 2019, (2019), 143-151]鈴木貴、岩渕英里奈、三木康宏、高木清司、笹野公伸
4.[] Cytochrome c1 as a favorable prognostic marker in estrogen receptor-positive breast carcinoma..[Histology and histopathology,(2019),18130-]Sato A, Takagi K, Miki Y, Yoshimura A, Hara M, Ishida T, Sasano H, Suzuki T
10.14670/HH-18-130
http://www.ncbi.nlm.nih.gov/pubmed/31149728
[2018]
5.[] OLFM4, LY6D and S100A7 as potent markers for distant metastasis in estrogen receptor-positive breast carcinoma..[Cancer science,109(10),(2018),3350-3359]Mayama A, Takagi K, Suzuki H, Sato A, Onodera Y, Miki Y, Sakurai M, Watanabe T, Sakamoto K, Yoshida R, Ishida T, Sasano H, Suzuki T
10.1111/cas.13770
http://www.ncbi.nlm.nih.gov/pubmed/30137688
6.[] Relaxin 2/RXFP1 Signaling Induces Cell Invasion via the β-Catenin Pathway in Endometrial Cancer..[International journal of molecular sciences,19(8),(2018)]Fue M, Miki Y, Takagi K, Hashimoto C, Yaegashi N, Suzuki T, Ito K
10.3390/ijms19082438
http://www.ncbi.nlm.nih.gov/pubmed/30126180
7.[] The interplay of endocrine therapy, steroid pathways and therapeutic resistance: Importance of androgen in breast carcinoma..[Molecular and cellular endocrinology,466,(2018),31-37]Takagi K, Miki Y, Ishida T, Sasano H, Suzuki T
10.1016/j.mce.2017.09.011
http://www.ncbi.nlm.nih.gov/pubmed/28918115
8.[] 17β-Hydroxysteroid Dehydrogenase Type 2 Expression Is Induced by Androgen Signaling in Endometrial Cancer..[International journal of molecular sciences,19(4),(2018)]Hashimoto C, Miki Y, Tanaka S, Takagi K, Fue M, Doe Z, Li B, Yaegashi N, Suzuki T, Ito K
10.3390/ijms19041139
http://www.ncbi.nlm.nih.gov/pubmed/29642629
9.[] ARHGAP15 in Human Breast Carcinoma: A Potent Tumor Suppressor Regulated by Androgens..[International journal of molecular sciences,19(3),(2018)]Takagi K, Miki Y, Onodera Y, Ishida T, Watanabe M, Sasano H, Suzuki T
10.3390/ijms19030804
http://www.ncbi.nlm.nih.gov/pubmed/29534468
10.[] The reduction of heparan sulphate in the glomerular basement membrane does not augment urinary albumin excretion..[Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,33(1),(2018),26-33]Aoki S, Saito-Hakoda A, Yoshikawa T, Shimizu K, Kisu K, Suzuki S, Takagi K, Mizumoto S, Yamada S, van Kuppevelt TH, Yokoyama A, Matsusaka T, Sato H, Ito S, Sugawara A
10.1093/ndt/gfx218
http://www.ncbi.nlm.nih.gov/pubmed/28992095
[2017]
11.[] 乳がんの増殖と生存に関わるエストロゲン応答性長鎖非コードRNAの役割.[日本内分泌学会雑誌,93(4), (2017), 1292]水戸部 悠一, 堀江 公仁子, 池田 和博, 高木 清司, 鈴木 貴, 井上 聡
12.[] 乳癌進行におけるOLFM4の役割の検討.[日本癌学会総会記事,76回, (2017), P-2184]小野寺 好明, 高木 清司, 真山 晃史, 三木 康宏, 笹野 公伸, 鈴木 貴
13.[] 子宮内膜癌におけるDehydroepiandrosterone(DHEA)の作用.[日本癌学会総会記事,76回, (2017), P-3202]吉田 伶奈, 三木 康宏, 笛 未崎, 高木 清司, 鈴木 貴, 伊藤 潔
14.[] 乳癌組織における腫瘍随伴マクロファージに対するアンドロゲンの影響の解析.[日本癌学会総会記事,76回, (2017), P-2201]佐藤 正康, 高木 清司, 三木 康宏, 石田 孝宣, 笹野 公伸, 鈴木 貴
15.[] Cytochrome c1 in ductal carcinoma in situ of breast associated with proliferation and comedo necrosis..[Cancer science,108(7),(2017),1510-1519]Chishiki M, Takagi K, Sato A, Miki Y, Yamamoto Y, Ebata A, Shibahara Y, Watanabe M, Ishida T, Sasano H, Suzuki T
10.1111/cas.13251
http://www.ncbi.nlm.nih.gov/pubmed/28394473
16.[] 免疫組織化学法の実験デザイン.[組織細胞化学,2017, (2017), 45-55]鈴木 貴, 小野 克彦, 高木 清司
17.[] Interaction with adipocyte stromal cells induces breast cancer malignancy via S100A7 upregulation in breast cancer microenvironment..[Breast cancer research : BCR,19(1),(2017),70-]Sakurai M, Miki Y, Takagi K, Suzuki T, Ishida T, Ohuchi N, Sasano H
10.1186/s13058-017-0863-0
http://www.ncbi.nlm.nih.gov/pubmed/28629450
18.[] p62/sequestosome 1 in human colorectal carcinoma as a potent prognostic predictor associated with cell proliferation..[Cancer medicine,6(6),(2017),1264-1274]Nakayama S, Karasawa H, Suzuki T, Yabuuchi S, Takagi K, Aizawa T, Onodera Y, Nakamura Y, Watanabe M, Fujishima F, Yoshida H, Morikawa T, Sase T, Naitoh T, Unno M, Sasano H
10.1002/cam4.1093
http://www.ncbi.nlm.nih.gov/pubmed/28544335
19.[] Retinoic Acid Receptor β: A Potential Therapeutic Target in Retinoic Acid Treatment of Endometrial Cancer..[International journal of gynecological cancer : official journal of the International Gynecological Cancer Society,27(4),(2017),643-650]Tsuji K, Utsunomiya H, Miki Y, Hanihara M, Fue M, Takagi K, Nishimoto M, Suzuki F, Yaegashi N, Suzuki T, Ito K
10.1097/IGC.0000000000000995
http://www.ncbi.nlm.nih.gov/pubmed/28375930
20.[] 乳癌におけるcarcinoembryonic antigen-related cell adhesion molecule 6および8の発現意義の検討.[日本病理学会会誌,106(1), (2017), 347]岩渕 英里奈, 三木 康宏, 高木 清司, 小野寺 好明, 柴原 裕紀子, 鈴木 貴, 笹野 公伸
Page: [1] [2] [3] [4] [5] [6] [next]
戻るこのページのトップへ
copyright(c)2005 Tohoku University